Publication | Closed Access
Murine tyrosinase Inhibitors from <i>Cynanchum bungei</i> and evaluation of <i>in vitro</i> and <i>in vivo</i> depigmenting activity
34
Citations
16
References
2011
Year
Molecular PharmacologyMedicinal ChemistryTranslational PharmacologyAllergyMurine TyrosinaseChemoprevention StrategyMedicineMurine Tyrosinase InhibitorsSkin HyperpigmentationNeuropharmacologyPharmacotherapyAnti-cancer AgentDermatologyPharmacologyInhibitory ActivityDrug DiscoveryOxidative Stress
Two natural acetophenone derivatives, 2,5-dihydroxyacetophenone (2,5-DHAP) and 2,6-DHAP, were purified from Cynanchum bungei and identified as murine tyrosinase inhibitors. Investigation into 2,5-DHAP showed it to be an uncompetitive inhibitor of murine tyrosinase (K(I) 0.28 mm). 2,5-DHAP strongly inhibited both melanogenesis and cellular tyrosinase activity in vitro in 3-isobutyl-1-methylxanthin-stimulated B16 mouse melanoma cells or in vivo in zebrafish and mouse models, but showed no cytotoxicity at the concentrations used. In B16 cells, 2,5-DHAP inhibition was dose-dependent and was fourfold greater than that of arbutin. 2,5-DHAP had no effect on the expression of tyrosinase protein or mRNA, as confirmed by Western blotting and quantitative real-time reverse transcription polymerase chain reaction, respectively. A 2% gel preparation of 2,5-DHAP applied to the skin of mice significantly increased the average skin-whitening index (L value), indicating its potential use as a treatment for skin hyperpigmentation in humans.
| Year | Citations | |
|---|---|---|
1986 | 731 | |
1997 | 344 | |
2007 | 248 | |
2010 | 137 | |
2010 | 134 | |
2010 | 107 | |
2009 | 67 | |
2008 | 65 | |
2009 | 52 | |
2009 | 48 |
Page 1
Page 1